HI HB767

Authorizes clinical psychologists who meet specific education and training requirements to prescribe psychotropic medications in consultation with a primary care provider, effective July 1, 2018.

Requires applicants to hold a post-doctoral master's degree in clinical psychopharmacology, complete minimum 800 hours of supervised clinical experience, and pass the nationally recognized Psychopharmacology Examination for Psychologists.

Restricts prescribing psychologists from prescribing Schedule I, II, or III controlled substances, opiates, and narcotic drugs, but permits stimulants for attention deficit hyperactivity disorder treatment.

Mandates collaborative agreements between prescribing psychologists and primary care providers, with monthly review of medication orders and documented consultations in patient medical records.

Requires prescribing psychologists to register with the Drug Enforcement Administration, maintain 18 hours of biennial continuing education in psychopharmacology, and prohibits delegation of prescriptive authority to others.